Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Replication defective adenoviruses are promising vectors for the delivery of vaccine antigens. However, the potential of a vector to elicit transgene-specific adaptive immune responses is largely dependent on the viral serotype used. HAdV-5 (Human adenovirus C) vectors are more immunogenic than chimpanzee adenovirus vectors from species Human adenovirus E (ChAdOx1 and AdC68) in mice, though the mechanisms responsible for these differences in immunogenicity remain poorly understood. In this study, superior immunogenicity was associated with markedly higher levels of transgene expression in vivo, particularly within draining lymph nodes. To investigate the viral factors contributing to these phenotypes, we generated recombinant ChAdOx1 vectors by exchanging components of the viral capsid reported to be principally involved in cell entry with the corresponding sequences from HAdV-5. Remarkably, pseudotyping with the HAdV-5 fiber and/or penton RGD loop had little to no effect on in vivo transgene expression or transgene-specific adaptive immune responses despite considerable species-specific sequence heterogeneity in these components. Our results suggest that mechanisms governing vector transduction after intramuscular administration in mice may be different from those described in vitro.

Original publication

DOI

10.1038/srep16756

Type

Journal article

Journal

Sci Rep

Publication Date

18/11/2015

Volume

5

Keywords

Adenoviridae, Adenoviruses, Human, Animals, Antibodies, Viral, Antigen-Presenting Cells, Antigens, Viral, CD8-Positive T-Lymphocytes, Capsid Proteins, Gene Expression, Genetic Vectors, Humans, Immunity, Immunization, Injections, Intramuscular, Mice, Orexin Receptors, Pan troglodytes, Transduction, Genetic, Transgenes, Vaccines